COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 1519: Articles 15181-15190  | Next

SARS-CoV-2 convergent evolution as a guide to explore adaptive advantage
Zahradnik, J., Nunvar, J., Schreiber, G.
10.1101/2021.05.24.445534 — Posted: 2021-05-25
Divergent early antibody responses define COVID-19 disease trajectories
Chakraborty, S., Gonzalez, J. C., Sievers, B. L., Mallajosyula, V., Dubey, M., Cheng, Y.-L. B., Tran, K. Q. T., Chakraborty, S., Cassidy, A., Chen, S. T., Sinnott, A., Gelbart, T., Golan, Y., Prahl, M., Singh, U., Kim-Schulze, S., Sherwood, R., Zhang, S., Marron, T. U., Gnjatic, S., Gaw, S. L., Nadeau, K. C., Merad, M., Jagannathan, P., Tan, G. S., Wang, T. T.
10.1101/2021.05.25.445649 — Posted: 2021-05-25 Discussion: Offsite
Infection of brain pericytes underlying neuropathology of COVID-19 patients
Bocci, M., Oudenaarden, C., Saenz-Sarda, X., Simren, J., Eden, A., Sjölund, J., Möller, C., Gisslen, M., Zetterberg, H., Englund, E., Pietras, K.
10.1101/2021.05.24.445532 — Posted: 2021-05-25 Discussion: Onsite
Evolutionary Inference Predicts Novel ACE2 Protein Interactions Relevant to COVID-19 Pathologies
Varela, A. A., Cheng, S., Werren, J. H.
10.1101/2021.05.24.445517 — Posted: 2021-05-25
Genomic Surveillance of COVID-19 Variants with Language Models and Machine Learning
Nagpal, S., Pal, R., Ashima, , Tyagi, A., Tripathi, S., Nagori, A., Ahmad, S., Mishra, H. P., Kutum, R., Sethi, T.
10.1101/2021.05.25.445601 — Posted: 2021-05-25
Exploiting Molecular Basis of Age and Gender Differences in Outcomes of SARS-CoV-2 Infections.
Mercatelli, D., Pedace, E., Giorgi, F. M., Guzzi, P. H.
10.1101/2021.05.23.21257669 — Posted: 2021-05-25
Identification of site-specific evolutionary trajectories shared across human betacoronaviruses
Escalera-Zamudio, M., Kosakovsky Pond, S. L., Martinez de la Vina, N., Gutierrez, B., Theze, J., Bowden, T. A., Pybus, O. G., Hulswit, R. J. G.
10.1101/2021.05.24.445313 — Posted: 2021-05-25
Impact of Glycosylation on SARS-CoV-2 Infection and Broadly Protective Vaccine Design
Liao, H.-Y., Huang, H.-Y., Chen, X., Cheng, C.-W., Wang, S.-W., Shahed-Al-Mahmud, M., Chen, T.-H., Lo, J. M., Liu, Y.-M., Ma, H.-H., Chang, Y.-H., Tsai, C.-Y., Huang, P.-Y., Chang, S.-Y., Chao, T.-L., Kao, H.-C., Tsai, Y.-M., Chen, Y.-H., Chen, C.-Y., Lee, K.-C., Wu, C.-Y., Jan, J.-T., Lin, K.-I., Cheng, T.-J. R., Ma, C., Wong, C.-H.
10.1101/2021.05.25.445523 — Posted: 2021-05-25
An Issue of Concern: Unique Truncated ORF8 Protein Variants of SARS-CoV-2
Hassan, S. S., Kodakandla, V., Redwan, E. M., Lundstrom, K., Pal Choudhury, P., Abd El-Aziz, T. M., Takayama, K., Kandimalla, R., Lal, A., Serrano-Aroca, A., Azad, G. K., Aljabali, A. A. A., Palu, G., Chauhan, G., Adadi, P., Tambuwala, M., Brufsky, A., Baetas-da-Cruz, W., Barh, D., Bazan, N. G., Uversky, V. N.
10.1101/2021.05.25.445557 — Posted: 2021-05-25
Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization.
Varona, J. F., Landete, P., Lopez-Martin, J. A., Estrada, V., Paredes, R., Guisado-Vasco, P., Fernandez de Orueta, L., Torralba, M., Fortun, J., Vates, R., Barberan, J., Clotet, B., Ancochea, J., Carnevali, D., Cabello, N., Porras, L., Gijon, P., Monereo, A., Abad, D., Zuniga, S., Sola, I., Rodon, J., Izquierdo-Useros, N., Fudio, S., Pontes, M. J., de Rivas, B., Giron de Velasco, P., Sopesen, B., Nieto, A., Gomez, J., Aviles, P., Lubomirov, R., White, K. M., Rosales, R., Yildiz, S., Reuschl, A.-K., Thorne, L. G., Jolly, C., Towers, G. J., Zuliani-Alvarez, L., Bouhaddou, M., Obernier, K., Enjuanes, L., Fernandez-Sousa, J. M., Plitidepsin COVID Study Group, , Krogan, N. J., Jimeno, J. M., Garcia-Sastre, A.
10.1101/2021.05.25.21257505 — Posted: 2021-05-25 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).